22nd Century Group, Inc. (XXII)
-OTC BB 0.60 May 22, 3:30PM EDT|Pre-Market
:
NaN
| Prev Close: | 0.60 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 5.00 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.15 - 1.07 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 73,444 |
|---|
| Market Cap: | 23.40M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.22 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 22ND CENTURY GROUP, INC. FinancialsEDGAR Online Financials(Tue, May 21)
- 22ND CENTURY GROUP, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- 22nd Century Group’s Goodrich Tobacco Company Grants Exclusive Distribution Rights For Very Low Nicotine Cigarette Brand in BeneluxBusiness Wire(Tue, Apr 16)
- 22nd Century announces U.S. patent issues for MPO nicotine biosynthesis genetheflyonthewall.com(Wed, Apr 3)
- 22nd Century Group Announces U.S. Patent Issues for MPO Nicotine Biosynthesis GeneBusiness Wire(Wed, Apr 3)
- 22ND CENTURY GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhiEDGAR Online(Mon, Mar 25)
- 22ND CENTURY GROUP, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Mar 18)
- 22nd Century Group Investors Convert $1.7 Million of Notes into Common StockBusiness Wire(Wed, Feb 6)
- 22ND CENTURY GROUP, INC. Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Wed, Feb 6)
- 22nd Century Group Subsidiary, Goodrich Tobacco, Applies for Federal License to Manufacture Tobacco ProductsBusiness Wire(Thu, Jan 31)
- 22ND CENTURY GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EquityEDGAR Online(Thu, Jan 17)
- 22nd Century Group Closes $2.5 Million Private PlacementBusiness Wire(Mon, Jan 14)
- 22ND CENTURY GROUP, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, Jan 14)
- 22nd Century Group Announces Allowance of U.S. Patent for MPO Nicotine Biosynthesis GeneBusiness Wire(Thu, Jan 3)
- 22ND CENTURY GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Wed, Jan 2)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1,246.44 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.
View More 
0.52%